The prothrombotic state in atrial fibrillation: New insights, more questions, and clear answers needed

American Heart Journal

Volumn 140, Issue 3, 2000, Pages 348-350

  Lip, Gregory Y H ^a  

^a University Department of Medicine   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA THROMBOGLOBULIN; WARFARIN;

CARDIOVERSION; CLINICAL FEATURE; CLINICAL TRIAL; EDITORIAL; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERCOAGULABILITY; HYPERTENSION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR; THROMBOGENESIS;

EID: 0033835587     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2000.108521     Document Type: Article

References (29)

1. Left atrial spontaneous echo contrast in mitral valve disease: An indicator for an increased thromboembolic risk
2. Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in non-rheumatic atrial fibrillation
3. Intracardiac thrombus formation in cardiac impairment: Investigation and the role of anticoagulant therapy
4. Atrial fibrillation in hypertension: Under-recognised or over-diagnosed?
5. Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with atrial fibrillation
6. Endocardial damage is common in the left atrial appendage of patients with mitral valve disease: Implications for left atrial thrombogenesis
7. Does atrial fibrillation confer a hypercoagulable state?
8. Does heart failure confer a hypercoagulable state? Virchow's triad revisited
9. Does hypertension confer a prothrombotic state?
10. Increased cardiovascular clotting in patients with chronic atrial fibrillation
11. Effect of degree of blood pressure on the hypercoagulable state in chronic atrial fibrillation
12. Markers of thrombin and platelet activity in patients with atrial fibrillation. Correlation with stroke among 1531 participants in the Stroke Prevention in Atrial Fibrillation III Study
13. Effect of fixed minidose warfarin, conventional dose warfarin and aspirin on INR and prothrombin fragment 1+2 in patients with atrial fibrillation
14. Effects of fixed, low-dose warfarin, aspirin-warfarin combination therapy and dose-adjusted warfarin on thrombogenesis in chronic atrial fibrillation
15. Determinants of increased regional left atrial coagulation activity in patients with mitral stenosis
16. Coagulation activity is increased in the left atrium of patients with mitral stenosis
17. Indices of hypercoagulability measured in peripheral blood reflect levels in intracardiac blood in patients with atrial fibrillation secondary to mitral stenosis
18. Stroke with intermittent atrial fibrillation: Incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators
19. Plasma fibrinogen and fibrin D-dimer levels in paroxysmal atrial fibrillation: Evidence for intermediate levels of intravascular thrombogenesis
20. Atrial fibrillation activates platelets and coagulation in a time-dependent manner: A study in patients with paroxysmal atrial fibrillation
21. Spontaneous echo contrast in the left atrium during paroxysmal atrial fibrillation
22. Coagulation indicators in patients with paroxysmal atrial fibrillation: Effects of electrical and pharmacological cardioversion
23. Fibrin D-dimer: A useful clinical marker of thrombogenesis?
24. Molecular markers in thrombosis and hemostasis
25. Plasma fibrinogen and fibrin D-dimer levels in atrial fibrillation: Effect of cardioversion to sinus rhythm
26. Activation of the haemostatic mechanism after pharmacological cardioversion of acute nonvalvular atrial fibrillation
27. Is there a difference in thrombogenesis between patients with paroxysmal, persistent and permanent atrial fibrillation?
28. Antithrombotic therapy in atrial fibrillation
29. Aggravation of postcardioversion atrial dysfunction by sotalol